GUGGENHEIM CAPITAL LLC - APRICUS BIOSCIENCES INC ownership

APRICUS BIOSCIENCES INC's ticker is APRIXXXX and the CUSIP is 03832V109. A total of 29 filers reported holding APRICUS BIOSCIENCES INC in Q4 2013. The put-call ratio across all filers is 9.02 and the average weighting 0.0%.

Quarter-by-quarter ownership
GUGGENHEIM CAPITAL LLC ownership history of APRICUS BIOSCIENCES INC
ValueSharesWeighting
Q3 2016$10,000
+42.9%
29,480
+59.4%
0.00%
Q2 2016$7,000
-36.4%
18,5000.0%0.00%
Q1 2016$11,000
-68.6%
18,500
+19.1%
0.00%
Q2 2014$35,000
-5.4%
15,539
-9.1%
0.00%
Q1 2014$37,000
+5.7%
17,093
+29.4%
0.00%
Q4 2013$35,000
+34.6%
13,206
+6.3%
0.00%
Q3 2013$26,000
-10.3%
12,4220.0%0.00%
Q2 2013$29,00012,4220.00%
Other shareholders
APRICUS BIOSCIENCES INC shareholders Q4 2013
NameSharesValueWeighting ↓
Sarissa Capital Management LP 6,524,505$6,459,0001.26%
Healthcare Value Capital, LLC 140,000$139,0000.23%
Healthcare Value Capital, LLC 100,000$99,0000.16%
McQueen, Ball & Associates Inc. 25,000$25,0000.02%
Callan Capital, LLC 55,735$55,0000.02%
Financial Architects, Inc 10,166$10,0000.00%
Hudson Bay Capital Management LP 51,814$51,0000.00%
SPHINX TRADING, LP 1,266$1,0000.00%
HighTower Advisors, LLC 48,867$48,0000.00%
BANK OF AMERICA CORP /DE/ 28,500$28,0000.00%
View complete list of APRICUS BIOSCIENCES INC shareholders